Last $136.23 USD
Change Today -0.36 / -0.26%
Volume 837.9K
BCR On Other Exchanges
Symbol
Exchange
Frankfurt
As of 8:04 PM 04/24/14 All times are local (Market data is delayed by at least 15 minutes).

cr bard inc (BCR) Snapshot

Open
$136.41
Previous Close
$136.59
Day High
$137.14
Day Low
$135.34
52 Week High
04/1/14 - $150.13
52 Week Low
04/25/13 - $98.04
Market Cap
10.4B
Average Volume 10 Days
890.0K
EPS TTM
$5.89
Shares Outstanding
76.3M
EX-Date
04/24/14
P/E TM
23.1x
Dividend
$0.84
Dividend Yield
0.62%
Current Stock Chart for CR BARD INC (BCR)

cr bard inc (BCR) Related Businessweek News

No Related Businessweek News Found

cr bard inc (BCR) Details

C. R. Bard, Inc. designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices worldwide. It offers vascular products, including percutaneous transluminal angioplasty catheters, chronic total occlusion catheters, guidewires, fabrics, meshes, introducers, and accessories; valvuloplasty balloons; peripheral vascular stents, covered stents, and vascular grafts; vena cava filters; biopsy devices; and temporary pacing electrode catheters for the treatment of peripheral vascular disease and heart arrhythmias. The company’s urology products include Foley catheters to reduce the rate of urinary tract infections; surgical slings to treat stress urinary incontinence; fecal incontinence products; devices for the treatment of pelvic floor and vaginal prolapse; brachytherapy services, devices, and radioactive seeds to treat prostate cancer; intermittent urinary drainage catheters, and urine monitoring and collection systems; ureteral stents; specialty devices for stone removal; catheter stabilization devices; and products for therapeutic hypothermia. It also provides specialty vascular access catheters and ports, vascular access ultrasound devices, dialysis access catheters, and enteral feeding devices to treat and manage various cancers and other diseases and disorders. In addition, the company offers surgical specialty products, such as implanted grafts and fixation devices for hernia and soft tissue repair products; surgical sealants for intraoperative sealing of air leaks in thoracic surgery; and other products that include irrigation, wound drainage, and original equipment manufacturers’ products. It sells its products directly to hospitals, individual healthcare professionals, extended care facilities, and alternate site facilities, as well as through hospital/surgical supply and other medical specialty distributors. C. R. Bard, Inc. was founded in 1907 and is headquartered in Murray Hill, New Jersey.

13,000 Employees
Last Reported Date: 02/19/14
Founded in 1907

cr bard inc (BCR) Top Compensated Officers

Chairman, Chief Executive Officer and Chairma...
Total Annual Compensation: $1.1M
President, Chief Operating Officer and Direct...
Total Annual Compensation: $887.0K
Group President
Total Annual Compensation: $660.0K
Group President
Total Annual Compensation: $560.0K
Chief Financial Officer and Senior Vice Presi...
Total Annual Compensation: $540.0K
Compensation as of Fiscal Year 2013.

cr bard inc (BCR) Key Developments

C. R. Bard, Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2014; Provides Earnings Guidance for the Second Quarter of 2014; Reaffirms Earnings Guidance for 2014

C. R. Bard Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2014. For the quarter, net sales were $799,300,000 against $740,300,000 for the same period in the last year. Income from operations before income taxes was $183,600,000 against $127,600,000 for the same period in the last year. Net income was $148,400,000 or $1.86 per diluted share available to common shareholders against $90,700,000 or $1.08 per diluted share available to common shareholders for the same period in the last year. Adjusted earnings were $152.6 million or $1.91 per diluted share against $135.3 million or $1.61 per diluted share for the same period in the last year. Net Sales were up 8% over the first quarter last year on both an as reported and a constant currency basis. Currency impact for the quarter was unfavorable by about 10 basis points. The net impact from acquisitions, less the EP divestiture, was a benefit of the about 40 basis points to revenue in first quarter. Capital expenditures totaled $22.7 million for the quarter. For the second quarter, the company expects gross margin to be at a similar level to the prior year second quarter. The company expects constant currency sales growth between 6% and 8%. From an adjusted EPS standpoint, excluding items affecting comparability, the company sees second quarter in the range of $1.98 per share to $2.02 per share, consistent with the expectation of improvement as it moves through the year. The company is sticking with its original guidance for 2014 as it believes markets continue to experience uncertainty. The company remains focused on delivering adjusted EPS between $8.20 and $8.30 for the full year.

CR Bard Inc. Declares Quarterly Dividend, Payable on May 9, 2014

CR Bard Inc. declared a regular quarterly dividend of 21 cents per share on Bard's common stock. The current indicated annual dividend rate is 84 cents per share. The dividend is payable on May 9, 2014 to shareholders of record at the close of business on April 28, 2014.

CR Bard Inc., Q1 2014 Earnings Call, Apr 22, 2014

CR Bard Inc., Q1 2014 Earnings Call, Apr 22, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BCR:US $136.23 USD -0.36

BCR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CareFusion Corp $38.39 USD +0.13
Endo International PLC $61.86 USD -0.16
Sigma-Aldrich Corp $94.76 USD +0.94
Varian Medical Systems Inc $78.74 USD -2.57
View Industry Companies
 

Industry Analysis

BCR

Industry Average

Valuation BCR Industry Range
Price/Earnings 14.8x
Price/Sales 3.4x
Price/Book -- Not Meaningful
Price/Cash Flow 14.2x
TEV/Sales -- Not Meaningful
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CR BARD INC, please visit www.crbard.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.